Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Tokyo Joe's Cafe / Societe Anonyme/No Pennies -- Ignore unavailable to you. Want to Upgrade?

To: MoneyMade who wrote (10308)	11/12/1998 11:26:00 AM
From: HiSpeed	Respond to of 119973

From Briefing.com: 09:44 ET EntreMed Inc (ENMD) 23 1/8 -9 1/2 (-29%): Shares of biotech stock that started the "cancer-cure" mania down 29% this morning on a Wall Street Journal report that other scientists have been unable to duplicate angiostatin findings

To: MoneyMade who wrote (10308)	11/12/1998 1:04:00 PM
From: kha vu	Read Replies (2) \| Respond to of 119973

WSJ front page has an article about the Havard lab that was successful in producing the molecule which can stop BLOOD feeding those cancer cells and starved these cell to death........However, no other labs in the world including the NIH lab could reproduce this experiment using the Havard protocol...In other word, this protocol of experiment is in question...ie the ENMD ...the company that sponsored this lab and has right to the patent is suffering....financially